Striking costs of infertility point to importance of IVF access and affordability
By Beth Duff-Brown,
Stanford Institute for Economic Policy Research
| 07. 12. 2024
The debate over in vitro fertilization (IVF) has become a hot-button policy and political issue, despite the medical procedure to help people become pregnant having been mainstream in the United States for nearly half a century.
The Alabama Supreme Court recently ruled that embryos are children under the law — prompting at least three fertility clinics in that state to halt treatment — and more than a dozen other states are considering IVF restrictions. In June, the Southern Baptist Convention, the nation’s largest Protestant denomination, voted to oppose IVF treatments, while the U.S. Senate blocked legislation that would have made it a nationwide right for women to access fertility treatments.
These developments beg the question: How would making IVF unavailable affect the many couples who are building their dreams of a family on the use of this technology?
A new Stanford study provides novel, concrete evidence on how these involuntarily infertile couples are affected: infertility leads to poorer mental health among both partners and a hefty hike in the likelihood of divorce.
Petra Persson, an assistant professor of economics...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...